Dyadic International
Yahoo Finance • 3 days ago
Dyadic Expands IP Protection and Business Development Activities in Japan
JUPITER, Fla., June 29, 2026 (GLOBE NEWSWIRE) -- Dyadic International, Inc. (Nasdaq: DYAI) (“Dyadic” or the “Company”), d/b/a Dyadic Applied BioSolutions, a biotechnology company focused on the development and commercialization of scalab... Full story
Yahoo Finance • 17 days ago
Dyadic Highlights Accelerated Interest in C1 Biomanufacturing Platform Amid Ebola Preparedness Activities and Growing Commercial Adoption
JUPITER, Fla., June 15, 2026 (GLOBE NEWSWIRE) -- Dyadic International, Inc. (Nasdaq: DYAI), d/b/a Dyadic Applied BioSolutions (“Dyadic” or the “Company”), a biotechnology company focused on the development and commercialization of scalab... Full story
Yahoo Finance • 29 days ago
Dyadic (DYAI) Q1 2026 Earnings Call Transcript
Image source: The Motley Fool. DATE Wednesday, March 25, 2026 at 5 p.m. ET CALL PARTICIPANTS President and Chief Operating Officer — Joseph Hazelton Chief Executive Officer — Mark Emalfarb Chief Financial Officer — Ping Rawson Need a... Full story
Yahoo Finance • last month
Dyadic Applied BioSolutions Announces Participation in Sidoti Virtual Investor Conference
JUPITER, Fla., May 19, 2026 (GLOBE NEWSWIRE) -- Dyadic International, Inc. (“Dyadic,” “we,” “us,” “our,” or the “Company”) (NASDAQ: DYAI), d/b/a Dyadic Applied BioSolutions, a global biotechnology company producing precision-engineered,... Full story
Yahoo Finance • 2 months ago
Dyadic outlines cash runway into Q2 2027 while targeting mid-2026 alpha-lactalbumin sampling
Earnings Call Insights: Dyadic International (DYAI) Q1 2026 MANAGEMENT VIEW * “Over the last several years, we have worked to transform Dyadic from a platform technology company into a commercially focused biotechnology company capable... Full story
Yahoo Finance • 2 months ago
Dyadic Announces First Quarter 2026 Financial Results and Highlights Recent Company Progress
Received initial purchase orders for recombinant bovine transferrin from customers in the cultivated meat industryCommercial launch of AlbuFree™ DX recombinant human albumin by Proliant Health & Biologicals using Dyadic’s production platfo... Full story
Yahoo Finance • 3 months ago
Dyadic Announces 2025 Financial Results and Highlights Recent Company Progress
Commercial launch of AlbuFree™ DX recombinant human albumin by Proliant Health & Biologicals using Dyadic’s production platform, with Dyadic eligible to receive a share of profits from product salesExpanded strategic collaboration with Fer... Full story
Yahoo Finance • 4 months ago
Life Sciences Virtual Investor Forum Presentations Now Available for Online Viewing
NEW YORK, March 13, 2026 (GLOBE NEWSWIRE) -- Virtual Investor Conferences, the leading proprietary investor conference series, today announced that presentations from the Life Sciences Virtual Investor Forum, held March 11th – 12th, are... Full story
Yahoo Finance • 4 months ago
Dyadic to Report 2025 Full Year Financial Results and Host Conference Call on Wednesday, March 25, 2026
JUPITER, Fla., March 11, 2026 (GLOBE NEWSWIRE) -- Dyadic International, Inc. d/b/a Dyadic Applied BioSolutions ("Dyadic", "we", "us", "our", or the "Company") (Nasdaq: DYAI), a global biotechnology company focused on the scalable product... Full story
Yahoo Finance • 8 months ago
Dyadic outlines new commercial focus as first bulk protein sales and Asia expansion accelerate growth trajectory
Earnings Call Insights: Dyadic International, Inc. (DYAI) Q3 2025 MANAGEMENT VIEW * President & COO Joseph Hazelton highlighted a pivotal shift, stating Dyadic is now operating as a “commercially focused biotechnology company with a gr... Full story
Yahoo Finance • 8 months ago
Dyadic Announces Third Quarter 2025 Financial Results and Highlights Strategic Progress
CompletedstrategicpivotfromR&Dfocustocommercial focusRebranded as Dyadic Applied BioSolutions and launched redesigned website to optimize commercial engagement and investor relationsAdvancedmultiplerecombinantproteinprogramstowardcommercia... Full story
Yahoo Finance • 8 months ago
Dyadic to Report Third Quarter 2025 Financial Results on Wednesday, November 12, 2025
JUPITER, Fla., Oct. 29, 2025 (GLOBE NEWSWIRE) -- Dyadic International, Inc. d/b/a Dyadic Applied BioSolutions (“Dyadic”, “we”, “us”, “our”, or the “Company”) (Nasdaq: DYAI), a global biotechnology company focused on the scalable producti... Full story
Yahoo Finance • 11 months ago
Dyadic anticipates $500,000 milestone and targets commercialization ramp through 2026
Earnings Call Insights: Dyadic International, Inc. (DYAI) Q2 2025 MANAGEMENT VIEW * Joseph P. Hazelton, President & COO, stated Dyadic has shifted from a platform-focused R&D company to a commercially-driven biotechnology business, emp... Full story
Yahoo Finance • 11 months ago
Earnings call transcript: Dyadic Q2 2025 sees revenue growth, stock dips
Dyadic International Inc. (DYAI) reported its financial results for the second quarter of 2025, showing significant revenue growth but a continued net loss. The company posted an EPS of -0.06, matching forecasts, while revenue slightly exc... Full story
- T
Mentioned:
Yahoo Finance • 11 months ago
Dyadic International Inc (NASDAQ:DYAI) Reports Mixed Q2 2025 Earnings Amid Strategic Rebranding
Dyadic International Inc (NASDAQ:DYAI [https://www.chartmill.com/stock/quote/DYAI]) reported its second-quarter 2025 financial results, delivering mixed performance against analyst expectations. The company, which recently rebranded as Dya... Full story
Yahoo Finance • 11 months ago
Dyadic Reports Second Quarter 2025 Financial Results and Highlights of Recent Company Progress
Completed Strategic Leadership and Operational Transformation from R&D to Commercial OperationsRebranded as Dyadic Applied BioSolutions to Reflect Our New Operational PrioritiesFull Redesign of Corporate Website to Prioritize Commercial Ex... Full story
Yahoo Finance • 11 months ago
Dyadic to Report Second Quarter 2025 Financial Results on Wednesday, August 13, 2025
JUPITER, Fla., Aug. 05, 2025 (GLOBE NEWSWIRE) -- Dyadic International, Inc. (“Dyadic”, “we”, “us”, “our”, or the “Company”) (Nasdaq: DYAI), a global biotechnology company focused on the scalable production of high-value, precision engine... Full story
Yahoo Finance • 11 months ago
UPDATE: Dyadic International, Inc. Announces Pricing of Public Offering of 6,052,000 Shares of Common Stock
JUPITER, Fla., July 31, 2025 (GLOBE NEWSWIRE) -- Dyadic International, Inc. (“Dyadic” or the “Company”) (Nasdaq: DYAI), a global biotechnology company focused on the scalable production of high-value, precision engineered functional inpu... Full story
Yahoo Finance • 11 months ago
Dyadic International, Inc. Announces Pricing of Public Offering of 6,052,000 Shares of Common Stock
JUPITER, Fla., July 31, 2025 (GLOBE NEWSWIRE) -- Dyadic International, Inc. (“Dyadic” or the “Company”) (Nasdaq: DYAI), a global biotechnology company focused on the scalable production of high-value, precision engineered functional inpu... Full story
Yahoo Finance • 11 months ago
Wednesday's after hours session: top gainers and losers
After the closing bell on Wednesday, let's take a glimpse of the US markets and explore the top gainers and losers in today's after-hours session. [postmarket] GAINERS TICKER CHANGE COMMENT HTOOW [https://www.chartmill.com/st... Full story